TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35148588

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (LP; 8 mmHg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (SP; 14 mmHg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (LP and SP)
Number of subjects: 62
Study: 32448781

Group type: EXPERIMENTAL
Intervention: Facilitator-mediated implementation package (group A)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Self-directed implementation package (group B)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care (control) (group C)
Number of subjects: 55
Study: 34363762

Group type: EXPERIMENTAL
Intervention: Avelumab maintenance (10 mg/kg intravenously every 2 weeks)
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Avelumab combination (10 mg/kg intravenously every 3 weeks)
Number of subjects: 998

Group type: COMPARATOR
Intervention: Control (chemotherapy followed by observation)
Number of subjects: 998
Study: 35964041

Group type: EXPERIMENTAL
Intervention: LH-based flexible GnRH antagonist protocol
Number of subjects: 216

Group type: COMPARATOR
Intervention: Traditional flexible GnRH antagonist protocol
Number of subjects: 216
Study: 33982405

Group type: EXPERIMENTAL
Intervention: Difelikefalin 1.0 mcg/kg i.v.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Difelikefalin 5.0 mcg/kg i.v.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32241693

Group type: EXPERIMENTAL
Intervention: Adjuvant targeted therapy (TT)
Number of subjects: 41027

Group type: COMPARATOR
Intervention: No adjuvant targeted therapy (TT)
Number of subjects: 41027
Study: 36253020

Group type: EXPERIMENTAL
Intervention: Self-management Programme of Activity, Coping and Education (SMP) delivered in groups over 5 months
Number of subjects: 193
Study: 34050550

Group type: EXPERIMENTAL
Intervention: E-PsEYE intervention (internet-based guided self-help course)
Number of subjects: 90
Study: 33113552

Group type: EXPERIMENTAL
Intervention: Nivolumab (anti-PD1) first-line therapy
Number of subjects: 0
Study: 33033014

Group type: EXPERIMENTAL
Intervention: Endotracheal tube plus stylet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endotracheal tube alone (control group)
Number of subjects: 0
Study: 35997971

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 91

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 91
Study: 33257276

Group type: EXPERIMENTAL
Intervention: Movement System Impairment‐Based classification model (MSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching and strengthening exercises for chronic LBP
Number of subjects: 0
Study: 32917317

Group type: EXPERIMENTAL
Intervention: PPE 400 mg per day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 36094202

Group type: COMPARATOR
Intervention: Ensitrelvir 20, 70, 250, 500, 1,000, or 2,000 mg (part 1)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Ensitrelvir 375/125 mg or 750/250 mg once daily for 5 days (part 2)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Ensitrelvir 750/250 mg coadministered with midazolam
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (part 1 and part 2)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Food intake effect on ensitrelvir
Number of subjects: 83
Study: 32315330

Group type: EXPERIMENTAL
Intervention: Hyperoxic conditions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normoxic conditions
Number of subjects: 25
Study: 35705512

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study: 34740265

Group type: EXPERIMENTAL
Intervention: Collagen barrier (Test group)
Number of subjects: 94

Group type: COMPARATOR
Intervention: No collagen barrier (Control group)
Number of subjects: 94
Study: 33402623

Group type: EXPERIMENTAL
Intervention: Tell-show-do technique with the aid of a virtual tool
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tell-show-do technique without the aid of a virtual tool
Number of subjects: 90
Study: 32396614

Group type: EXPERIMENTAL
Intervention: Autologous stem-cell transplant (ASCT) after first relapse
Number of subjects: 478
Study: 35166054

Group type: EXPERIMENTAL
Intervention: SAR342434 insulin lispro
Number of subjects: 36

Group type: COMPARATOR
Intervention: Humalog insulin lispro
Number of subjects: 36
Study: 33518076

Group type: EXPERIMENTAL
Intervention: Cage-free housing (CF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional cages (CC)
Number of subjects: 50
Study: 32195731

Group type: EXPERIMENTAL
Intervention: AI-enabled fluoroscopy system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional fluoroscopy system
Number of subjects: 100
Study: 35477870

Group type: EXPERIMENTAL
Intervention: Supervised physical activity intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 124
Study: 32122626

Group type: EXPERIMENTAL
Intervention: Conventional microbiological cultures
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Staphylococcus aureus
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Coagulase-negative Staphylococcus
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Staphylococcus epidermidis
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Methicillin-resistant S. aureus (MRSA)
Number of subjects: 137
Study: 33894327

Group type: EXPERIMENTAL
Intervention: Golexanolone (10, 40 or 80 mg BID)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 33079152

Group type: EXPERIMENTAL
Intervention: 15-mg/d vericiguat
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: 10-mg/d vericiguat
Number of subjects: 789

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 789
Study: 34653328

Group type: EXPERIMENTAL
Intervention: Liquid L-thyroxine (T4® drops)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Tablets L-thyroxine (T4® tablets)
Number of subjects: 39
Study: 34893133

Group type: EXPERIMENTAL
Intervention: Calcitriol combined with sirolimus
Number of subjects: 146

Group type: COMPARATOR
Intervention: Sirolimus (control group)
Number of subjects: 146
Study: 35232647

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: UDCA
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Digestive Enzyme
Number of subjects: 152
Study: 36036664

Group type: COMPARATOR
Intervention: Implementation strategies (educational materials, educational outreach, educational meetings)
Number of subjects: 1917

Group type: COMPARATOR
Intervention: Implementation strategies
Number of subjects: 1917
Study: 33174636

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) evaluation for high-grade lacerations
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) evaluation for high-grade lacerations
Number of subjects: 32
Study: 32610351

Group type: EXPERIMENTAL
Intervention: Multimodal approach (mCM) using navigated task-specific fMRI and direct cortical stimulation (DCS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Electrical cortical mapping (eCM) using DCS alone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: DCS with nfMRI
Number of subjects: 21
Study: 33180542

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (target BAC = .08%)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: High arousal positive (HIGH+) expectancies
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: High arousal negative (HIGH-) expectancies
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control for prior drinking
Number of subjects: 258
Study: 34886117

Group type: EXPERIMENTAL
Intervention: Mobile and internet-based aftercare program including psychoeducation, individual crisis plan, optional counseling via internet chat or phone, and supportive monitoring module.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mobile and internet-based aftercare program
Number of subjects: 25

Group type: COMPARATOR
Intervention: Recruitment process
Number of subjects: 25
Study: 32736555

Group type: EXPERIMENTAL
Intervention: Experiential Learning (EL) intervention, which included a lively presentation on oral health and role play in a simulated dental clinic.
Number of subjects: 988

Group type: COMPARATOR
Intervention: Tell-Show-Do (TSD) control group, which involved conventional behavior management.
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Experiential Learning (EL) intervention
Number of subjects: 988
Study: 35614590

Group type: EXPERIMENTAL
Intervention: Static stretching with range of motion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine post-operative care
Number of subjects: 30
Study: 33326555

Group type: EXPERIMENTAL
Intervention: Oil-soluble contrast media (OSCM) for hysterosalpingography (HSG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water-soluble contrast media (WSCM)
Number of subjects: 0
Study: 36451510

Group type: EXPERIMENTAL
Intervention: Self-gravitation traction at 40% or 60% of body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-gravitation traction at 20% of body weight (control)
Number of subjects: 0
Study: 35078520

Group type: EXPERIMENTAL
Intervention: Pediatric Tuina plus conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 0
Study: 32620155

Group type: EXPERIMENTAL
Intervention: β‐sitosterol enriched saw palmetto oil
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional saw palmetto oil
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 36114133

Group type: EXPERIMENTAL
Intervention: Cardioneuroablation (CNA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (optimal nonpharmacologic therapy)
Number of subjects: 48
Study: 34400398

Group type: EXPERIMENTAL
Intervention: Mandatory CEL activities
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Voluntary CEL activities
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mandatory and voluntary CEL activities
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Barriers to engagement
Number of subjects: 15
Study: 35349214

Group type: EXPERIMENTAL
Intervention: Single bolus of 1 mmol/kg 23.4% sodium chloride (Group 1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Split bolus of 0.5 mmol/kg 23.4% sodium chloride (Group 2)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison of pain between groups
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison of IOP reduction between groups
Number of subjects: 33
Study: 32789723

Group type: EXPERIMENTAL
Intervention: Flare covered self-expandable metal stent (SEMS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: ComVi double-layered covered self-expandable metal stent (SEMS)
Number of subjects: 60
Study: 34557956

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham PBM therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both groups (PBM and Sham)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PBM therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 14
Study: 34032882

Group type: EXPERIMENTAL
Intervention: Tracheal tube + stylet
Number of subjects: 999

Group type: COMPARATOR
Intervention: Tracheal tube alone
Number of subjects: 999
Study: 32075612

Group type: EXPERIMENTAL
Intervention: TPB-based education intervention conducted in four educational sessions over 1 month.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TPB-based education intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 100
Study: 36259747

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with Indigenous narrative options
Number of subjects: 368

Group type: COMPARATOR
Intervention: Standard curriculum physical education practice
Number of subjects: 368
Study: 33206400

Group type: EXPERIMENTAL
Intervention: Counselling programme plus jaw exercises
Number of subjects: 70

Group type: COMPARATOR
Intervention: Counselling programme
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison between counselling programme and counselling plus jaw exercises
Number of subjects: 70
Study: 35942923

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT; 1-min bouts at 100% WRpeak, 3 sessions/week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT; 50% peak work rate)
Number of subjects: 20
Study: 32872012

Group type: EXPERIMENTAL
Intervention: Gualou Danshen granules (GLDS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34270471

Group type: EXPERIMENTAL
Intervention: Carpal Tunnel Syndrome (CTS) patients
Number of subjects: 9442

Group type: COMPARATOR
Intervention: Controls (no CTS)
Number of subjects: 9442

Group type: EXPERIMENTAL
Intervention: Risk factors for CTS
Number of subjects: 9442
Study: 32954647

Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dripping pills (QSYQ) for 6 months
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dripping pills (QSYQ)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study: 33907224

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g tablet formulation
Number of subjects: 36
Study: 32404279

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 39
Study: 32969469

Group type: EXPERIMENTAL
Intervention: Educated group (133 patients)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (130 patients)
Number of subjects: 263
Study: 34488845

Group type: EXPERIMENTAL
Intervention: Low-cell dose treatment group (n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-cell dose treatment group (n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 90
Study: 32013106

Group type: EXPERIMENTAL
Intervention: Sport Education (n = 74)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Traditional Teaching (n = 74)
Number of subjects: 148
Study: 35227127

Group type: EXPERIMENTAL
Intervention: Pro-environmental prenatal education program
Number of subjects: 96
Study: 35659571

Group type: EXPERIMENTAL
Intervention: Response-adjusted protocol (n=27) with tapering doses of prednisone over 8 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual care group (n=32) with standard protocol (60 mg/m2/24 hours for 6 weeks, followed by 40 mg/m2/48 hours for 4 weeks, followed by a slow taper for a total of 24 weeks)
Number of subjects: 59
Study: 35793466

Group type: EXPERIMENTAL
Intervention: Straight-tip guidewire
Number of subjects: 88

Group type: COMPARATOR
Intervention: J-tip guidewire
Number of subjects: 88
Study: 34273257

Group type: EXPERIMENTAL
Intervention: Apalutamide-applesauce mixture
Number of subjects: 12

Group type: COMPARATOR
Intervention: Whole tablets of apalutamide
Number of subjects: 12
Study: 32103926

Group type: EXPERIMENTAL
Intervention: Budesonide/Glycopyrrolate/Formoterol Fumarate (BUD/GLY/FORM) triple therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Budesonide/Formoterol Fumarate (BUD/FORM) dual therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Run-in period
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: BUD/GLY/FORM triple therapy
Number of subjects: 19
Study: 34450102

Group type: EXPERIMENTAL
Intervention: Autologous HSCT (myeloablative radiochemotherapy followed by autologous HSCT)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Interferon alfa maintenance (6 × 106 IU three times a week subcutaneously until progression)
Number of subjects: 269
Study: 32393320

Group type: EXPERIMENTAL
Intervention: Usual care including home exercise (UCHE) plus spa therapy (18 days of mud packs, underwater massages, showers and water exercises under medical supervision)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Usual care including home exercise (UCHE) alone
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: UCHE plus spa therapy
Number of subjects: 358

Group type: COMPARATOR
Intervention: UCHE alone
Number of subjects: 358
Study: 32370582

Group type: EXPERIMENTAL
Intervention: Indirect questioning about the acceptability of wife-beating
Number of subjects: 809

Group type: COMPARATOR
Intervention: Direct questioning about the acceptability of wife-beating
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Participants with less education (<3 years schooling)
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Participants living in households where women do not participate in economic decision making
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Adults with higher levels of education
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Adults living in households where decision making is shared between couples
Number of subjects: 809
Study: 35010328

Group type: EXPERIMENTAL
Intervention: Intervention group in neutral location
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Intervention group in contextualized location
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (leaflet)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Intervention groups (neutral and contextualized)
Number of subjects: 268
Study: 33322686

Group type: EXPERIMENTAL
Intervention: Usual care plus community-level intervention delivered by local AN 'Native Sisters'
Number of subjects: 352

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 352
Study: 34785236

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg, once daily)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33242515

Group type: EXPERIMENTAL
Intervention: Adherence to prescribed medications
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Adherence to diet plans
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Middle-aged (50–64 years)
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Presence of microvascular complications
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Longer duration of diabetes (>15 years)
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Hyperlipidemia
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Younger age group (35–49 years vs. >64 years)
Number of subjects: 1146
Study: 32762226

Group type: EXPERIMENTAL
Intervention: Hemocoagulase treatment in patients with low coagulation index (CI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group with normal coagulation index (CI)
Number of subjects: 43
Study: 35525415

Group type: EXPERIMENTAL
Intervention: Augmented reality training system (AR group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Instructional video (video group)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups (AR and video)
Number of subjects: 38
Study: 32897569

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX) 1 g intravenous initially, then every 6 months for 12 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Glatiramer acetate (GA) 40 mg subcutaneously 3 times/week for 12 months
Number of subjects: 84
Study: 36476684

Group type: EXPERIMENTAL
Intervention: Translucent zirconia (4Y-PSZ) restorations
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lithium disilicate ceramic restorations (LD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Bi-layered zirconia restorations (BL)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dispersed nanoparticle-filled composite resin restorations (CM)
Number of subjects: 44
Study: 33435932

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 30245

Group type: EXPERIMENTAL
Intervention: Individuals with disordered eating behaviors
Number of subjects: 30245

Group type: COMPARATOR
Intervention: Alcohol use
Number of subjects: 30245

Group type: COMPARATOR
Intervention: Sunbed use
Number of subjects: 30245

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 30245

Group type: EXPERIMENTAL
Intervention: Loss‐of‐control eating
Number of subjects: 30245
Study: 32410586

Group type: EXPERIMENTAL
Intervention: Care availability for perinatal depression at the primary care level
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Perceived health benefits of treatment for perinatal depression
Number of subjects: 42

Group type: COMPARATOR
Intervention: Stigma and negative stereotypes expressed by care providers
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Individual patient resilience
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Providers trained in management of perinatal depression
Number of subjects: 42

Group type: COMPARATOR
Intervention: Unsupportive and stigmatizing clinic environments
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Interventions to reduce stigma among healthcare providers
Number of subjects: 42
Study: 36964526

Group type: EXPERIMENTAL
Intervention: Group Education (GE)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Person-Centered Support (PCS)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Group Education (GE) and Person-Centered Support (PCS)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 370
Study: 33476048

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32826784

Group type: EXPERIMENTAL
Intervention: Yoga intervention (2× weekly, 60-minute sessions for 12 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Delayed treatment (control)
Number of subjects: 150
Study: 34657138

Group type: EXPERIMENTAL
Intervention: AGMG0201 (active study drug)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AGMG0201 (high-dose group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AGMG0201 (low-dose group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33024120

Group type: EXPERIMENTAL
Intervention: Probiotics + Berberine (BBR)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Berberine (BBR) alone
Number of subjects: 409

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409

Group type: COMPARATOR
Intervention: Probiotics alone
Number of subjects: 409
Study: 35470006

Group type: EXPERIMENTAL
Intervention: Electric heating moxibustion (EM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acupuncture (AC)
Number of subjects: 40